Label-free quantification of membrane-ligand interactions using backscattering interferometry

Nature Biotechnology

Volumn 29, Issue 4, 2011, Pages 357-360

  Baksh, Michael M ^a   Kussrow, Amanda K ^b   Mileni, Mauro ^a   Finn, M G ^a   Bornhop, Darryl J ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING INTERACTION; DRUG TARGETS; EQUILIBRIUM BINDING CONSTANT; GENERAL METHOD; HIGH SENSITIVITY; LABEL FREE; LIGAND BINDING; LIGAND INTERACTIONS; LIGAND-RECEPTOR BINDING; LIVING ORGANISMS; MEMBRANE PROTEINS; MEMBRANE-ASSOCIATED PROTEINS; MOLECULE INTERACTIONS; NATIVE MEMBRANES;

BACKSCATTERING; BINDING ENERGY; BIOLOGICAL MEMBRANES; BIOLOGY; EQUILIBRIUM CONSTANTS; INTERFEROMETRY; LIGANDS; REFRACTIVE INDEX;

PROTEINS;

MEMBRANE PROTEIN;

ACCURACY; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CONTROLLED STUDY; COST; HUMAN; HUMAN CELL; INTERFEROMETRY; LIGAND BINDING; MEMBRANE BINDING; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STUDY;

AMIDOHYDROLASES; CHOLERA TOXIN; G(M1) GANGLIOSIDE; HUMANS; INTERFEROMETRY; KINETICS; LIGANDS; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; PROTEIN BINDING; RECEPTORS, CXCR4; RECEPTORS, GABA-B; REFRACTOMETRY;

EID: 79953839803     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.1790     Document Type: Article

References (33)

1. Krummel, M.F. & Davis, M.M. Dynamics of the immunological synapse: fnding, establishing and solidifying a connection. Curr. Opin. Immunol. 14, 66-74 (2002). (Pubitemid 34085108)
2. Overington, J.P., Al-Lazikani, B. & Hopkins, A.L. How many drug targets are there? Nat. Rev. Drug Discov. 5, 993-996 (2006). (Pubitemid 44835126)
3. Wise, A., Gearing, K. & Rees, S. Target validation of G-protein coupled receptors. Drug Discov. Today 7, 235-246 (2002). (Pubitemid 34143072)
4. Markov, D.A., Swinney, K. & Bornhop, D.J. Label-free molecular interaction determinations with nanoscale interferometry. J. Am. Chem. Soc. 126, 16659-16664 (2004). (Pubitemid 40081968)
5. Sorensen, H.S., Larsen, N.B., Latham, J.C., Bornhop, D.J. & Andersen, P.E. Highly sensitive biosensing based on interference from light scattering in capillary tubes. Appl. Phys. Lett. 89, 151108 (2006).
6. Bornhop, D.J. et al. Free-solution, label-free molecular interactions studied by back-scattering interferometry. Science 317, 1732-1736 (2007). (Pubitemid 47461834)
7. Kussrow, A. et al. Measurement of monovalent and polyvalent carbohydrate-lectin binding by back-scattering interferometry. Anal. Chem. 81, 4889-4897 (2009).
8. Sonnino, S., Mauri, L., Chigorno, V. & Prinetti, A. Gangliosides as components of lipid membrane domains. Glycobiology 17, 1R-13R (2007). (Pubitemid 44932810)
9. Fishman, P.H., Pacuszka, T. & Orlandi, P.A. Gangliosides as receptors for bacterial enterotoxins. Adv. Lipid Res. 25, 165-187 (1993).
10. Kuziemko, G.M., Stroh, M. & Stevens, R.C. Cholera toxin binding affnity and specifcity for gangliosides determined by surface plasmon resonance. Biochemistry 35, 6375-6384 (1996). (Pubitemid 26164071)
11. Fang, Y., Frutos, A. & Lahiri, J. Ganglioside microarrays for toxin detection. Langmuir 19, 1500-1505 (2003).
12. Cannon, B. et al. Cholesterol modulated antibody binding in supported lipid membranes as determined by total internal refectance microscopy on a microfabricated high-throughput glass chip. Langmuir 21, 9666-9674 (2005). (Pubitemid 41507022)
13. Brian, A.A. & McConnell, H.M. Allogenic stimulation of cyto-toxic T-cell by supported planar membranes. Proc. Natl. Acad. Sci. USA 81, 6159-6163 (1984). (Pubitemid 15220799)
14. Mossman, K.D., Campi, G., Groves, J.T. & Dustin, M.L. Altered TCR signaling from geometrically repatterned immunological synapses. Science 310, 1191-1193 (2005). (Pubitemid 41681746)
15. Cravatt, B.F. & Lichtman, A.H. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr. Opin. Chem. Biol. 7, 469-475 (2003). (Pubitemid 36980837)
16. Devane, W.A. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949 (1992). (Pubitemid 23026736)
17. Mileni, M. et al. Binding and inactivation mechanism of a humanized fatty acid amide hydrolase by α-ketoheterocycle inhibitors revealed from co-crystal structures. J. Am. Chem. Soc. 131, 10497-10506 (2009).
18. Boger, D.L. et al. Discovery of a potent, selective, and effcacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics. J. Med. Chem. 48, 1849-1856 (2005). (Pubitemid 40396316)
19. Romero, F.A. et al. Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase. J. Med. Chem. 50, 1058-1068 (2007). (Pubitemid 46394008)
20. Garfunkle, J. et al. Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase. J. Med. Chem. 51, 4392-4403 (2008).
21. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108 (1973).
22. Hesselgesser, J. et al. Identifcation and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity. J. Immunol. 160, 877-883 (1998). (Pubitemid 28049330)
23. B receptor. Biochem. Pharmacol. 68, 1565-1572 (2004). (Pubitemid 39286461)
24. B receptors by 2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol. Pharm. 60, 963-971 (2001). (Pubitemid 33027431)
25. B sites. Neuropharmacology 24, 207-210 (1985). (Pubitemid 15051587)
26. B agonist with CNS activity. Bioorg. Med. Chem. Lett. 3, 515-518 (1993). (Pubitemid 23109555)
27. B agonists. J. Med. Chem. 38, 3297-3312 (1995).
28. Brugger, F., Wicki, U., Olpe, H.R., Froestl, W. & Mickel, S. The action of new potent GABA-B receptor antagonists in the hemisected spinal cord preparation of the rat. Eur. J. Pharmacol. 235, 153-155 (1993). (Pubitemid 23124085)
29. Latham, J.C., Stein, R.A., Bornhop, D.J. & Mchaourab, H.S. Free-solution label-free detection of α-crystallin chaperone interactions by back-scattering interferometry. Anal. Chem. 81, 1865-1871 (2009).
30. Burns, J.M. et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203, 2201-2213 (2006). (Pubitemid 44352240)
31. Kaupmann, K. et al. Expression cloning of GABAB receptors uncovers similarity to metabotropic glutamate receptors. Nature 386, 239-246 (1997). (Pubitemid 27142503)
32. Kussrow, A.K. et al. The potential of backscattering interferometry as an in vitro clinical diagnostic tool for the serological diagnosis of infectious disease. Analyst (Lond.) 135, 1535-1537 (2010).
33. Kussrow, A., Baksh, M.M., Bornhop, D.J. & Finn, M.G. Universal sensing by transduction of antibody binding using backscattering interferometry. ChemBioChem 12, 367-370 (2011).